Sign up
Quantellect · Congress · Trade Detail
NYSE: ABBVAbbVie Inc
DemocratHouse

Debbie Dingell bought AbbVie Inc (NYSE: ABBV)

Debbie Dingell (D-MI), a U.S. Representative, has disclosed 4 trades in AbbVie Inc (ABBV) since 2016, 3 purchases and 1 sale, worth an estimated $124K in disclosed volume (the midpoint of the dollar ranges members report, not exact amounts).

The trade highlighted here is a purchase: Debbie Dingell bought $15,001 - $50,000 of AbbVie Inc (NYSE: ABBV) on October 13, 2020. Since that trade, ABBV is up +275.35% against the S&P 500 up +124.76%, an outperformance of +150.60%.

Across these filings, Debbie Dingell has been a net buyer of ABBV (a buy-to-sell ratio of 3.00). The most recent disclosed ABBV transaction shown was dated June 18, 2021. Each row in the table below links to that trade and its post-trade performance versus the market.

Data updated

ABBV trades
4
Disclosed Vol
$124K
Buys
3
75%
Sells
1
25%
Buy / Sell
3.00
ratio
First → Last
2016–2021

Debbie Dingell's ABBV trades vs the price

ABBV is up +275.35% since Debbie Dingell bought on October 13, 2020, versus +124.76% for the S&P 500.

Performance since this trade

Price change since trade
+275.35%
S&P 500 change since trade
+124.76%
Outperformance vs S&P 500
+150.60%

All Debbie Dingell ABBV trades

TradedTypeSizeReturnEst. profit
June 18, 2021SELL$93.77+180.78%
October 13, 2020BUY$70.15+275.35%+$65K
February 22, 2018BUY$82.74+218.22%+$10K
June 22, 2016BUY$39.99+558.38%+$27K

Estimated profit is shown for buys only, marked to the latest close. It is an estimate and does not net later sells, taxes, or fees.

Debbie Dingell & ABBV trading FAQ

Is it legal for Debbie Dingell to trade AbbVie Inc (ABBV) stock?

Yes. Members of Congress are allowed to trade individual stocks, including AbbVie Inc (ABBV), but the STOCK Act of 2012 requires them to publicly disclose each transaction within 45 days. Quantellect tracks those disclosures; this page does not imply the trade was improper.

When did Debbie Dingell buy ABBV?

Debbie Dingell disclosed a purchase of $15,001 - $50,000 of AbbVie Inc (ABBV) on October 13, 2020, according to public STOCK Act filings.

How has ABBV performed since Debbie Dingell's trade?

Since Debbie Dingell bought ABBV on October 13, 2020, the stock is up +275.35%, versus +124.76% for the S&P 500 over the same period, an outperformance of +150.60%.

How many times has Debbie Dingell traded ABBV?

Debbie Dingell has disclosed 4 ABBV trades since 2016 (3 purchases and 1 sale). Every disclosed trade is listed on this page.

How soon must members of Congress disclose a trade?

Under the STOCK Act, members of Congress must publicly report a covered transaction within 45 days of the trade. Filings can still be delayed, amended, or contain errors.

Where can I see all congressional ABBV trades?

Quantellect tracks every disclosed congressional trade in AbbVie Inc (ABBV) on the AbbVie Inc congressional trading page, which aggregates filings across all members of Congress.

Debbie Dingell's ABBV tradesAll congressional filings for AbbVie IncDebbie Dingell's full profile

Not investment advice. Congressional trading data is sourced from public STOCK Act disclosures, which are filed with a delay and may contain errors or be revised. Estimated prices and post-trade returns are derived algorithmically from public filings and end-of-day market data and describe historical activity, not a recommendation. Always do your own research and consult a licensed financial advisor before making investment decisions.